Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 638,500 | 610,800 | 681,122 | 632,124 | 681,110 |
| Cost of Goods | 283,400 | 284,900 | 314,805 | 296,441 | 318,627 |
| Gross Profit | 355,100 | 325,900 | 366,317 | 335,683 | 362,483 |
| Operating Expenses | 254,000 | 282,200 | 271,801 | 245,175 | 273,493 |
| Operating Income | 101,500 | 44,600 | 95,321 | 90,949 | 89,617 |
| Interest Expense | 12,300 | 12,300 | 12,322 | 12,398 | 12,343 |
| Other Income | -2,875,500 | 458,800 | 345,397 | 58,551 | -1,577,701 |
| Pre-tax Income | -2,786,300 | 491,100 | 428,396 | 137,102 | -1,500,427 |
| Income Tax | -620,800 | 107,200 | 78,664 | 30,845 | -338,176 |
| Net Income Continuous | -2,165,500 | 383,900 | 349,732 | 106,257 | -1,162,251 |
| Net Income | $-2,165,500 | $383,900 | $349,732 | $106,257 | $-1,162,251 |
| EPS Basic Total Ops | -76.26 | 13.46 | 11.79 | 3.65 | -39.59 |
| EPS Basic Continuous Ops | -76.26 | 13.46 | 11.79 | 3.65 | -39.59 |
| EPS Diluted Total Ops | -76.26 | 13.45 | 11.81 | 3.64 | -39.59 |
| EPS Diluted Continuous Ops | -76.26 | 13.45 | 11.82 | 3.64 | -39.59 |
| EPS Diluted Before Non-Recurring Items | 3.11 | 2.29 | 3.10 | N/A | N/A |
| EBITDA(a) | $101,500 | $44,600 | $95,321 | $90,949 | $89,617 |